Sergei M. Gryaznov - 31 Dec 2023 SCHEDULE 13G/A Report for MAIA BIOTECHNOLOGY, INC. Common Stock, $0.0001 par value (MAIA)

Filing Manager: Sergei M. Gryaznov
Reporting Manager: Sergei M. Gryaznov
Security: MAIA BIOTECHNOLOGY, INC. Common Stock, $0.0001 par value
Symbol: MAIA
Shares outstanding: 27,943,995 shares
Disclosed Ownership: 1,140,115 shares
Ownership: 4.1%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 17:27:29 UTC
Date of event: 31 Dec 2023
SEC: View on sec.gov

Quoteable Key Fact

"Sergei M. Gryaznov disclosed 4.1% ownership in MAIA BIOTECHNOLOGY, INC. Common Stock, $0.0001 par value (MAIA) on 31 Dec 2023."

Quick Takeaways

Sergei M. Gryaznov filed SCHEDULE 13G/A for MAIA BIOTECHNOLOGY, INC. Common Stock, $0.0001 par value (MAIA).
Disclosed ownership: 4.1%.
Date of event: 31 Dec 2023.

What Changed

No earlier schedule filing is available for direct comparison.
Current filing was accepted on 14 Feb 2025, 17:27.

Why This Matters

This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Sergei M. Gryaznov	4.1%	1,140,115	1,140,115	0	/s/ Sergei M. Gryaznov	Sergei M. Gryaznov

Explore related SEC datasets

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .